Suppr超能文献

自然抑制人类免疫缺陷病毒 1 型复制是由过渡性记忆 CD8+T 细胞介导的。

Natural suppression of human immunodeficiency virus type 1 replication is mediated by transitional memory CD8+ T cells.

机构信息

Department of Medicine, University of California San Francisco, San Francisco, California 94143-1270, USA.

出版信息

J Virol. 2011 Feb;85(4):1696-705. doi: 10.1128/JVI.01120-10. Epub 2010 Dec 8.

Abstract

HIV replication is suppressed in vitro by a CD8(+) cell noncytotoxic antiviral response (CNAR). This activity directly correlates with an asymptomatic clinical state. The objective of this study was to identify the phenotype of CD8(+) cell subsets having strong CNAR activity. CD8(+) cell subset frequencies and CNAR levels were measured for human immunodeficiency virus (HIV)-uninfected individuals and three groups of HIV type 1 (HIV-1)-infected individuals: asymptomatic individuals with low-level viremia (vHIV), antiretroviral-drug-treated subjects with undetectable virus levels (TxHIV), and therapy-naïve aviremic elite controllers (EC). CD8(+) cells from the vHIV individuals exhibited the highest HIV-suppressing activity and had elevated frequencies of CD45RA(-) CD27(+) and PD-1(+) (CD279(+)) cells. Functional assessments of CD8(+) cells sorted into distinct subsets established that maximal CNAR activity was mediated by CD45RA(-) CCR7(-) CD27(+) and PD-1(+) CD8(+) cells. T cell receptor (TCR) repertoire profiles of CD8(+) cell subsets having strong CNAR activity exhibited increased perturbations in comparison to those of inactive subsets. Together, these studies suggest that CNAR is driven by HIV replication and that this antiviral activity is associated with oligoclonally expanded activated CD8(+) cells expressing PD-1 and having a transitional memory cell phenotype. The findings better describe the identity of CD8(+) cells showing CNAR and should facilitate the evaluation of this important immune response in studies of HIV pathogenesis, resistance to infection, and vaccine development.

摘要

HIV 在体外的复制受到 CD8(+) 细胞非细胞毒性抗病毒反应 (CNAR) 的抑制。这种活性与无症状的临床状态直接相关。本研究的目的是确定具有强 CNAR 活性的 CD8(+)细胞亚群的表型。测量了人类免疫缺陷病毒 (HIV) 未感染个体以及三组 HIV 型 1 (HIV-1) 感染个体的 CD8(+)细胞亚群频率和 CNAR 水平:低病毒载量的无症状个体 (vHIV)、抗病毒药物治疗病毒水平不可检测的个体 (TxHIV) 和未经治疗的无病毒精英控制器 (EC)。vHIV 个体的 CD8(+)细胞表现出最高的 HIV 抑制活性,并且具有升高的 CD45RA(-)CD27(+)和 PD-1(+)(CD279(+))细胞频率。对不同亚群的 CD8(+)细胞进行的功能评估表明,最大的 CNAR 活性是由 CD45RA(-)CCR7(-)CD27(+)和 PD-1(+)CD8(+)细胞介导的。与非活性亚群相比,具有强 CNAR 活性的 CD8(+)细胞亚群的 T 细胞受体 (TCR) 谱特征显示出更大的扰动。这些研究表明,CNAR 是由 HIV 复制驱动的,这种抗病毒活性与表达 PD-1 并具有过渡性记忆细胞表型的寡克隆扩增激活 CD8(+)细胞有关。这些发现更好地描述了表现出 CNAR 的 CD8(+)细胞的特性,并应有助于评估这种重要免疫反应在 HIV 发病机制、感染抵抗和疫苗开发研究中的作用。

相似文献

3
The CD8 T Cell Noncytotoxic Antiviral Responses.
Microbiol Mol Biol Rev. 2021 May 12;85(2). doi: 10.1128/MMBR.00155-20. Print 2021 May 19.
7
Human Immunodeficiency Virus Type-1 Elite Controllers Maintain Low Co-Expression of Inhibitory Receptors on CD4+ T Cells.
Front Immunol. 2018 Jan 22;9:19. doi: 10.3389/fimmu.2018.00019. eCollection 2018.

引用本文的文献

1
Interplay between metabolic reprogramming and post-translational modifications: from glycolysis to lactylation.
Front Immunol. 2023 Jun 29;14:1211221. doi: 10.3389/fimmu.2023.1211221. eCollection 2023.
3
The CD8 T Cell Noncytotoxic Antiviral Responses.
Microbiol Mol Biol Rev. 2021 May 12;85(2). doi: 10.1128/MMBR.00155-20. Print 2021 May 19.
5
Canonical Wnts Mediate CD8 T Cell Noncytolytic Anti-HIV-1 Activity and Correlate with HIV-1 Clinical Status.
J Immunol. 2020 Oct 15;205(8):2046-2055. doi: 10.4049/jimmunol.1801379. Epub 2020 Sep 4.
7
Role of Different Subpopulations of CD8 T Cells during HIV Exposure and Infection.
Front Immunol. 2017 Aug 7;8:936. doi: 10.3389/fimmu.2017.00936. eCollection 2017.
8
Analysis of the CD8 T cell anti-HIV activity in heterologous cell co-cultures reveals the benefit of multiple HLA class I matches.
Immunogenetics. 2018 Feb;70(2):99-113. doi: 10.1007/s00251-017-1021-7. Epub 2017 Jul 22.
9
Gut Homing CD4+ and CD8+ T-Cell Frequencies in HIV Infected Individuals on Antiretroviral Treatment.
PLoS One. 2016 Nov 29;11(11):e0166496. doi: 10.1371/journal.pone.0166496. eCollection 2016.

本文引用的文献

2
CD8+ cell anti-HIV activity rapidly increases upon discontinuation of early antiretroviral therapy.
J Clin Immunol. 2009 May;29(3):311-8. doi: 10.1007/s10875-009-9275-y. Epub 2009 Feb 3.
4
PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.
J Exp Med. 2006 Oct 2;203(10):2281-92. doi: 10.1084/jem.20061496. Epub 2006 Sep 5.
5
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction.
Nat Med. 2006 Oct;12(10):1198-202. doi: 10.1038/nm1482. Epub 2006 Aug 20.
6
The PD-1-PD-L pathway in immunological tolerance.
Trends Immunol. 2006 Apr;27(4):195-201. doi: 10.1016/j.it.2006.02.001. Epub 2006 Feb 24.
7
A screening assay for detecting CD8+ cell non-cytotoxic anti-HIV responses.
J Immunol Methods. 2005 Sep;304(1-2):137-50. doi: 10.1016/j.jim.2005.07.016.
8
9
VCAM-1 expression on CD8+ cells correlates with enhanced anti-HIV suppressing activity.
J Immunol. 2005 Feb 1;174(3):1574-9. doi: 10.4049/jimmunol.174.3.1574.
10
Persistent alterations in the T-cell repertoires of HIV-1-infected and at-risk uninfected men.
AIDS. 2004 Jan 23;18(2):161-70. doi: 10.1097/00002030-200401230-00004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验